Skip to Content

Ferric Citrate use while Breastfeeding

Drugs containing Ferric Citrate: Auryxia

Medically reviewed by Drugs.com. Last updated on Feb 2, 2021.

Ferric Citrate Levels and Effects while Breastfeeding

Summary of Use during Lactation

Iron is a normal component of human milk. Studies on various forms of iron indicate that breastmilk levels are not increased greatly after exogenous administration. No special precautions are necessary. Holder pasteurization reduces the concentration of iron in milk by about 6.5%.[1]

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

References

1.
Mohd-Taufek N, Cartwright D, Davies M, et al. The effect of pasteurization on trace elements in donor breast milk. J Perinatol. 2016;36:897–900. [PubMed: 27253894]

Substance Identification

Substance Name

Ferric Citrate

CAS Registry Number

2338-05-8

Drug Class

Breast Feeding

Lactation

Ferric Compounds

Chelating Agents

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.